Biotech & pharma
Research proves plausibility of new primordial pathway to life’s chemical building blocks
02 Feb 2012
Metabolic errors can spell doom for DNA
By By Anne Trafton, MIT News Office | 01 Feb 2012
Many critical cell functions depend on a class of molecules called purines, which form half of the building blocks of DNA and RNA, and are a major component of the chemicals that store a cell’s energy. MIT biological engineers have precisely measured the effects of errors in systems for purine production and breakdown
Genetic breakthrough for brain cancer in children
31 Jan 2012
Research team identifies two mutations in crucial gene involved in deadly paediatric brain tumours
Researchers induce Alzheimer’s neurons from pluripotent stem cells
By By Scott LaFee | 27 Jan 2012
For the first time scientists have created stem cell-derived, in vitro models of sporadic and hereditary Alzheimer’s, using induced pluripotent stem cells from patients with the neurodegenerative disorder
Scientists link evolved, mutated gene module to syndromic autism
By By Debra Kain, Scott LaFee | 27 Jan 2012
Viruses con bacteria into working for them
27 Jan 2012
Scripps researchers illuminate cancer cells’ survival strategy during dangerous dissemination
27 Jan 2012
Envelope for an artificial cell
25 Jan 2012
How cells dispose of their waste
24 Jan 2012
Scientists create novel RNA repair technology
18 Jan 2012
Tiny worm points to big promise
13 Jan 2012
How research goes viral
By By Peter Dizikes, MIT News Office | 10 Jan 2012
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
